Analysis of peptidyl-propyl-cis/trans isomerase 1 (PIN1) gene −842(G > C) and −667(T > C) polymorphic variants in relation to breast cancer risk and clinico-pathological parameters

References

• Galat A. Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity-targets-functions. Curr Top Med Chem 2003;3:1315–47.
   PubMed Web of Science ®Google Scholar
• Lu KP, Suizu F, Zhou XZ, Finn G, Lam P, Wulf G. Targeting carcinogenesis: a role for the prolyl isomerase Pin1? Mol Carcinog 2006;45:397–402.
   PubMed Web of Science ®Google Scholar
• Lu KP, Liou YC, Zhou XZ. Pinning down proline-directed phosphorylation signaling. Trends Cell Biol 2002;12: 164–72.
   PubMed Web of Science ®Google Scholar
• Yeh ES, Means AR. PIN1, the cell cycle and cancer. Nat Rev Cancer 2007;7:381–8.
   PubMed Web of Science ®Google Scholar
• Lu KP, Hanes SD, Hunter T. A human peptidyl-prolyl isomerise essential for regulation of mitosis. Nature 1996;380: 544–7.
   PubMed Web of Science ®Google Scholar
• Ranganathan R, Lu KP, Hunter T, Noel JP. Structural and functional analysis of the mitotic peptidyl-prolyl isomerase Pin1 suggests that substrate recognition is phosphorylation dependent. Cell 1997;89:875–86.
   PubMed Web of Science ®Google Scholar
• Yaffe MB, Schutkowski M, Shen M, Zhou XZ, Stukenberg PT, Rahfeld JU, Xu J, Kuang J, Kirschner MW, Fischer G, Cantley LC, Lu KP. Sequence specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 1997;278:1957–60.
   PubMed Web of Science ®Google Scholar
• Bao L, Kimzey A, Sauter G, Sowadski JM, Lu KP, Wang D. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am J Pathol 2004;164:1727–37.
   PubMed Web of Science ®Google Scholar
• Ayala G, Wang D, Wulf G, Frolov A, Li R, Sowadski J, Wheeler TM, Lu KP, Bao L. The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res 2003;63:6244–51.
   PubMed Web of Science ®Google Scholar
• Wulf G, Garg P, Liou YC, Iglehart D, Lu KP. Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis. EMBO J 2004;23:3397–407.
   PubMed Web of Science ®Google Scholar
• Wulf GM, Ryo A, Wulf GG, Lee SW, Niu T, Lu KP. Pin1 is overexpressed in breast cancer and potentiates the transcriptional activity of phosphorylated c-Jun towards the cyclin D1 gene. EMBO J 2001;20:3459–72.
   PubMed Web of Science ®Google Scholar
• Ryo A, Liou YC, Wulf G, Nakamura N, Lee SW, Lu KP. Pin1 is an E2F target gene essential for the Neu/Ras-induced transformation of mammary epithelial cells. Mol Cell Biol 2002;22:5281–95.
   PubMed Web of Science ®Google Scholar
• Segat L, Milanese M, Crovella S. Pin1 promoter polymorphisms in hepatocellular carcinoma patients. Gastroenterology 2007;132:2618–2619.
   PubMed Web of Science ®Google Scholar
• Han CH, Lu J, Wei Q, Bondy ML, Brewster AM, Yu TK, Buchholz TA, Arun BK, Wang LE. The functional promoter polymorphism (2842G > C) in the PIN1 gene is associated with decreased risk of breast cancer in non-Hispanic white women 55 years and younger. Breast Cancer Res Treat 2010; 122:243–9.
   PubMed Web of Science ®Google Scholar
• Lu J, Hu Z, Wei S, Wang LE, Liu Z, El-Naggar AK, Sturgis EM, Wei Q. A novel functional variant (−842G/C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity. Carcinogenesis 2009;30:1717–21.
   PubMed Web of Science ®Google Scholar
• Segat L, Pontillo A, Annoni G, Trabattoni D, Vergani C, Clerici M, Arosio B, Crovella S. PIN1 promoter polymorphisms are associated with Alzheimer's disease. Neurobiol Aging 2007;28:69–74.
   PubMed Web of Science ®Google Scholar
• Lim GCC, Halimah Y. Second Report of the National Cancer Registry. Cancer Incidence in Malaysia 2003. National Cancer Registry. Kuala Lumpur, 2004.
   Google Scholar
• Naidu R, Har YC, Taib NA. Polymorphism of FGFR4 Gly388Arg does not confer an increased risk to breast cancer development. Oncol Res 2009;18(2-3):65–71.
   PubMed Web of Science ®Google Scholar
• Elston CW, Ellis IO. Pathological prognostic factors in breast cancer I. Histopathology 1991;19:403–10.
   PubMed Web of Science ®Google Scholar
• Bloom HI, Richardson WW. Histological grading and prognosis. Br J Cancer 1957;11:359–77.
   PubMed Web of Science ®Google Scholar
• American Joint Committee on Cancer. Breast. AJCC Cancer Staging Manual. 6th. New York: Springer, 2002; 171–80.
   Google Scholar
• Singletary ES, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, Borgen PI, Clark G, Edge BS, Hayes DF, Hughes LL, Hutter RVP, Morrow M, Page DL, Recht A, Theriault RL, Thor A, Weaver H, Wieland S, Greene FL. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002;20:3628–36.
   PubMed Web of Science ®Google Scholar
• Naidu R, Har YC, Taib NA. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer. J Exp Clin Cancer Res 2007; 26:133–40.
   PubMed Web of Science ®Google Scholar
• Lambert JC, Bensemain F, Chapuis J, Cottel D, Amouyel P. Association study of the PIN1 gene with Alzheimer's disease. Neurosci Lett 2006;402:259–61.
   PubMed Web of Science ®Google Scholar